TeraRecon is First to Pass Stringent New US Department of Defense Security Requirements
Mar 07, 2018 12:01 pm UTC| Business
Las Vegas, NV (HIMSS18), March 07, 2018 -- Las Vegas, NV – March 7th, 2018: TeraRecon today announced that its iNtuition™ Advanced Visualization solution has been granted an Authority to Operate (ATO) on networks in...
Mar 07, 2018 12:01 pm UTC| Business
Key Highlights Blockseer has an expanding team of blockchain, AI, and data scientists based in Silicon ValleyCustomer base has included Bitstamp, Intuit, and Blockchain.info, one of the world’s largest cryptocurrency...
Mar 07, 2018 12:01 pm UTC| Business
Interim analyses of STRIDE-1 and ADVANCE-1 trials of AXS-05 anticipated in 2018 Company to host conference call today at 8:00 AM Eastern NEW YORK, March 07, 2018 -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a...
TeraRecon is First to Pass Stringent New US Department of Defense Security Requirements
Mar 07, 2018 12:01 pm UTC| Business
Las Vegas, NV (HIMSS18), March 07, 2018 -- Las Vegas, NV – March 7th, 2018: TeraRecon today announced that its iNtuition™ Advanced Visualization solution has been granted an Authority to Operate (ATO) on networks in...
BioVie Responds to Japan Patent Office and Comments on Recent Stock Price Decline
Mar 07, 2018 12:01 pm UTC| Business
BEVERLY, Mass., March 07, 2018 -- BioVie Inc. (OTCQB:BIVI), a clinical-stage company focused on the development and commercialization of innovative drug therapies for liver disease, announced today that it submitted a...
Mar 07, 2018 12:01 pm UTC| Business
HOUSTON, March 07, 2018 -- Amplify Energy Corp. (OTCQX:AMPY) (“Amplify” or the “Company”) announced today its operating and financial results for the fourth quarter and full year 2017, year-end 2017 proved reserves and...
Proteostasis Therapeutics to Present at the Cowen and Company 38th Annual Health Care Conference
Mar 07, 2018 12:01 pm UTC| Business
CAMBRIDGE, Mass., March 07, 2018 -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic...